NCT00373880View on ClinicalTrials.gov

Effects of Aripiprazole on Cocaine Craving and Self-Administration

PHASE2CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

April 30, 2005

Primary Completion Date

August 31, 2008

Study Completion Date

September 30, 2008

Conditions
Cocaine Abuse
Interventions
DRUG

Aripiprazole + Cocaine

Participants received aripiprazole (15mg/day) in conjunction with a dose-response of cocaine (0, 12, 25, 50 mg).

DRUG

Placebo + Cocaine

Placebo (0 mg/day) in conjunction with a dose-response of cocaine (0, 12, 25, 50 mg).

Trial Locations (1)

10032

Irving Center for Clinical Research, New York

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

New York State Psychiatric Institute

OTHER

NCT00373880 - Effects of Aripiprazole on Cocaine Craving and Self-Administration | Biotech Hunter | Biotech Hunter